Skip to main content
    B

    Brainsway Ltd (BWAY)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.11
    -0.28 (-2.98%)

    Market Cap: $377.98M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Brainsway Ltd (BWAY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Brainsway (BWAY) has a market cap of $377.98M. Its share count is down 41.54% from a year earlier. Revenue grew 33.36% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$377.98M
    Latest price (Nov 17, 2026)$9.11

    Key Dates

    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 10.74% in the quarter ended Sep 30, 2026 and shrank 18.38% a year over 2 years.

    Shares Outstanding22.22M
    Shares Change (YoY)-41.54%
    Shares Change (QoQ)+10.74%
    Share Count Growth (2Y CAGR)-18.38%

    Valuation Ratios

    Sales and book value multiples are 3.1x and 2.5x.

    P/E Ratio25.0x
    Forward P/E11.1x
    P/S Ratio3.1x
    Forward P/S5.4x
    P/B Ratio2.5x
    P/FCF Ratio21.1x
    P/OCF Ratio29.2x
    PEG Ratio0.5

    Valuation history and multiples

    Price Statistics

    The stock is up 15.61% over 52 weeks and trades 24.46% below its 50-day average.

    Beta (1Y)2.09
    52-Week Change+15.61%
    1-Month Change-24.02%
    3-Month Change-39.95%
    6-Month Change-38.82%
    5-Year Change+177.75%
    Total Return (1Y)+15.61%
    Total Return (3Y CAGR)+56.41%
    Total Return (5Y CAGR)+17.94%
    Return vs SPY (1Y)+11.72%
    Max Drawdown (1Y)-46.94%
    Max Drawdown (3Y)-46.94%
    Sharpe Ratio (1Y)0.38
    Correlation with SPY (1Y)0.52
    50-Day Average$12.06
    200-Day Average$13.85
    52-Week Range$7.13 to $17.40
    RSI (14 Days)31.4
    Average Volume (20 Days)131.03K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.89x current liabilities.

    Current Ratio2.89x
    Quick Ratio2.62x
    Interest Coverage4.49x

    Returns and Efficiency

    Return on equity is 12.38% over the last 12 months, against a 5-year average of -7.13%.

    Return on Equity (ROE)12.38%
    Return on Assets (ROA)8.09%
    Return on Capital Employed (ROCE)10.95%
    ROE (5Y Average)-7.13%
    ROA (5Y Average)-5.21%
    ROIC (5Y Average)-6.15%
    Asset Turnover0.55x
    Inventory Turnover2.09x
    Receivables Turnover9.59x
    Cash Conversion Cycle158 days

    Scores

    BWAY has an Altman Z-Score of 3.16, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score3.16
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $65.47M over the last 12 months.

    Revenue$65.47M
    Revenue Growth (YoY)+33.36%
    Gross Profit$49.80M
    Operating Income$8.92M
    Pretax Income$10.06M
    Net Income$10.18M
    EBITDA$12.44M
    EBIT$10.70M
    Reported EPS (TTM)$0.36

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 65.33% of the $125.89M in total assets.

    Cash and Equivalents$30.05M
    Working Capital$53.32M
    Shareholder Equity$82.24M
    Total Assets$125.89M
    Total Liabilities$43.66M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.33M of capital spending, operating cash flow left $9.60M of free cash flow.

    Operating Cash Flow$12.93M
    Capital Expenditures$3.33M
    Free Cash Flow$9.60M
    FCF Per Share$0.24
    Depreciation and Amortization$1.74M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.63%, against a 5-year average of -13.49%.

    Gross Margin76.06%
    Operating Margin13.63%
    Pretax Margin15.36%
    Net Margin15.55%
    EBITDA Margin19.00%
    EBIT Margin16.35%
    FCF Margin14.67%
    Gross Margin (5Y Average)75.07%
    Operating Margin (5Y Average)-13.49%
    Net Margin (5Y Average)-12.47%

    Growth

    Revenue grew 24.33% a year over 3 years.

    Revenue Growth (3Y CAGR)+24.33%
    Revenue Growth (5Y CAGR)+18.81%

    Revenue and profit by year

    Dividends and Yields

    BWAY does not pay a dividend. Its free cash flow yield is 4.74%.

    Earnings Yield4.00%
    FCF Yield4.74%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 2-for-1 forward split on Mar 4, 2026.

    Last Split DateMar 4, 2026
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, BWAY has the 7th highest P/S.

    P/S Ratio3.1x vs 3.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)+33.36% vs +13.88% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 27.68% and EPS growth at 66.36% a year over the next 3 fiscal years.

    Revenue Growth Forecast (3Y CAGR)+27.68%
    EPS Growth Forecast (3Y CAGR)+66.36%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BWAY

    What is BWAY's market cap?

    Brainsway has a market cap of $377.98M.

    What is BWAY's P/E ratio?

    Brainsway has a trailing P/E ratio of 25.0x and a forward P/E of 11.1x.

    How many shares of BWAY are outstanding?

    Brainsway has 22.22M shares outstanding. The count is down 41.54% from a year earlier.

    Does BWAY pay a dividend?

    No. Brainsway does not pay a dividend.